Aragvadhadi Kwath in classical Ayurveda
In short
Aragvadhadi Kwath is a classical Ayurvedic preparation described in the Ashtanga Hridaya; it is used only under a qualified practitioner's guidance.
Good to know
This is not something to take on your own. If you are curious about it, a qualified practitioner and your doctor are the people to ask.
What it is
Aragvadhadi Kwath is a classical Ayurvedic herbal decoction, a kwath or kashayam, belonging to the Aragvadhadi group associated with Ashtanga Hridaya (Sutrasthana 15:17–18) (Ayurvedic formulary mirror). Its chief ingredient is aragvadha (Cassia fistula), combined with a long list of co-ingredients that commonly includes kutaja/indrayava, patala, nimba, guduchi, patha, bhunimba, sahachara, patola, karanja, chirabilva, chitraka, bitter gourd, and madanaphala (formulary mirror).
One point comes first, because it governs everything else on this page: ingredient lists and botanical mappings differ between sources. There is no single universal recipe. Whatever is on the product label is the formula you're actually discussing, not the classical list above. Verify the label.
Classical properties
- Taste (rasa): bitter (Tikta)
- Qualities (guna): light (Laghu)
- Potency (virya): cooling (Sheeta)
- After digestion (vipaka): pungent (Katu)
- Doshas: traditionally said to settle Pitta and Kapha; may increase Vata
Traditional use
In formulary tradition, Aragvadhadi preparations appear among the classical kashayam (decoction) compilations built around the Aragvadhadi group of herbs (formulary mirror). That is a statement about formulary tradition. It is not evidence of efficacy. We are saying this explicitly because for formulas like this one, the tradition section is often the whole marketing case, and here it has to stand alone: the human research comes next, and it is about a different preparation.
What research has looked at
Psoriasis study (related ghanvati form)
The closest thing to evidence is a 2024 single-blind randomized study from Gupta et al. in the Journal of Ayurveda and Integrated Medical Sciences. Forty-five psoriasis patients, three groups of 15. The relevant group received Aragvadhadi Gana ghanvati tablets for 45 days, together with topical Karanjadi Taila. PASI scores fell 29.25% within that group. But between-group differences were often not statistically significant (study, DOI: 10.21760/jaims.9.4.1).
A within-group drop that doesn't cleanly beat the other arms. We would call that a hint, not a result.
Why this is only indirect evidence
Here is the gap, and it is the whole story of this article. The study tested a concentrated tablet plus a topical oil. Not Aragvadhadi Kwath. Not the water decoction. Not alone. So whatever it found cannot be transferred to the kwath, full stop. A separate 2025 study combined a related kashayam with herbal bathing in 10 patients, which is the same problem in different clothes: a combination intervention, not evidence for the kwath alone (JAIMS 2025). No human trial of Aragvadhadi Kwath by itself was found. Anyone citing the psoriasis numbers for the decoction is misreading the study.
Safety notes
No published safety studies of Aragvadhadi Kwath itself were found. We want to be blunt about what that means: this is a complex multi-herb formula, its exact composition varies between manufacturers, and it includes pharmacologically active ingredients, so interactions and side effects cannot be ruled out. Safety in pregnancy, breastfeeding, and children is unestablished. The psoriasis study's ghanvati-plus-oil results cannot vouch for the kwath's safety, any more than the tablet's efficacy can. Anyone considering it should consult a qualified practitioner and verify the product's actual ingredient list.
FAQs
What is aragvadhadi kwath?
Aragvadhadi Kwath is a classical Ayurvedic herbal decoction, a kwath or kashayam, built around aragvadha (Cassia fistula), associated with the Aragvadhadi group of Ashtanga Hridaya. It is a multi-herb formula: published ingredient lists name many co-ingredients, but the exact composition varies between sources and manufacturers. Check the label, not the tradition.
What ingredients does it contain?
Commonly reported ingredients include aragvadha, kutaja (indrayava), patala, nimba, guduchi, patha, bhunimba, sahachara, patola, karanja, chirabilva, chitraka, bitter gourd, and madanaphala. But lists differ, and we mean that seriously. Because there is no single universal recipe in the sources found, always verify the actual ingredient list on the product label.
Does it help psoriasis?
The closest evidence is a 2024 randomized study in which 45 psoriasis patients received a related concentrated tablet (Aragvadhadi Gana ghanvati) plus a topical oil. PASI scores fell 29.25% within that group, though between-group differences were often nonsignificant. This tested the tablet-plus-oil combination, not the kwath decoction alone, so it does not prove the kwath helps psoriasis. Close is not the same.
Can I use the study's tablet dose for the kwath?
Swastik does not suggest amounts. The right amount depends on the person, the preparation and the product, so check with a qualified Ayurvedic practitioner or your doctor before taking any herb.
Is aragvadhadi kwath safe?
No published safety studies of the kwath itself were found. Its multi-herb composition varies between products and includes pharmacologically active ingredients, so interactions and side effects cannot be ruled out. Safety in pregnancy, breastfeeding, and children is unestablished. Consult a qualified practitioner before use, especially if you take other medicines.
What is the difference between a kwath and a ghanvati?
A kwath (kashayam) is a water decoction: herbs boiled in water, the liquid strained for use. A ghanvati is a concentrated tablet made by further boiling down a decoction into a solid extract and compressing it into pills. They differ in concentration, shelf life, and dosing, so evidence for one form does not automatically apply to the other. This distinction is doing a lot of work on this page.
Sources
Tier 2 — Peer-reviewed research
The psoriasis study is Gupta et al.'s single-blind randomized study of Aragvadhadi Gana ghanvati (45 days) with topical Karanjadi Taila in 45 psoriasis patients (15 per group), with a within-group PASI reduction of 29.25%, published in the Journal of Ayurveda and Integrated Medical Sciences in 2024 (DOI: 10.21760/jaims.9.4.1; study PDF). The second item is the 2025 combination study of a related kashayam (Aaragwadh Amritadi Kashayam) with Khadir herbal bathing in 10 patients: a combination intervention, not evidence for Aragvadhadi Kwath alone, published in JAIMS (article).
Tier 3 — Secondary and traditional references
The classical association and ingredient lists come from the Asoka Ayurveda formulary mirror: the classical kashayam listings including the Aragvadhadi group (asokaayurveda.com). This is a secondary traditional reference, used here for formulary identity only, not for any efficacy claim.
Disclaimer
This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use, especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.
Related herbs
Herbs with overlapping classical actions and dosha effects in the Swastik herb library.
- Aragwadha — shares Virechana + Kushtaghna actions; also pacifies Pitta & Kapha
- Aparajita — shares Kushtaghna actions; also pacifies Pitta & Kapha
- Asana — shares Kushtaghna actions; also pacifies Pitta & Kapha
- Asanadi Kwath — shares Kushtaghna actions; also pacifies Kapha & Pitta
- Asanadi Kwath — shares Kushtaghna actions; also pacifies Kapha & Pitta
- Dhamasa — shares Kushtaghna actions; also pacifies Pitta & Kapha
- Kadara — shares Kushtaghna actions; also pacifies Pitta & Kapha
- Kembuka — shares Kushtaghna actions; also pacifies Pitta & Kapha